Violeta Sanchez

10PUBLICATIONS
106CO-AUTHORS
Haematological tumoursImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 06, 2025
TREM2 expressing macrophages are not associated with prognostic markers or metabolic syndrome in early stage ER positive breast cancer.

Elysa W Pierro, Guadalupe A Garcia, Violeta M Sanchez

|Oct 10, 2025
The Impact of JAK1 Pathogenic Variants and MHC-I Expression on Response to Immune Checkpoint Inhibition in Endometrial Cancer.

Erica V Carballo, Paula Gonzalez-Ericsson, Brian D Lehmann

|Sep 19, 2025
Clonal Hematopoiesis of Indeterminate Potential Influences Breast Cancer Outcomes in a Genotype-Specific Manner.

Sarah C Reed, Chad R Potts, Leo Y Luo

|Jul 08, 2025
Phase Ib Trial of Fulvestrant, Palbociclib, and Erdafitinib, a pan-FGFR Tyrosine Kinase Inhibitor, in HR+/HER2- Metastatic Breast Cancer.

Paula I Gonzalez-Ericsson, Nisha Unni, Komal Jhaveri

|Jan 13, 2025
In Situ Detection of Individual Classic MHC-I Gene Products in Cancer.

Paula I Gonzalez-Ericsson, Susan R Opalenik, Violeta Sanchez

|Jul 15, 2024
Associations of Immune Checkpoint Predictive Biomarkers (MHC-I and MHC-II) with Clinical and Molecular Features in a Diverse Breast Cancer Cohort.

Xiaopeng Sun, Laura C Kennedy, Paula I Gonzalez-Ericsson

Pageof 2

Frequent Collaborators

10 joint publications

Paula I Gonzalez-Ericsson

7 joint publications

Justin M Balko

7 joint publications

Melinda Sanders

5 joint publications

Brian D Lehmann